Monoclonal antibodies against soybean Bowman-Birk protease inhibitor (BBI) have been generated and used to detect and quantify BBI in foods, soybean germplasm, and animal tissues and fluids. The purpose of this study was to determine the recognition sites of two monoclonal antibodies to BBI (mAb 238 and mAb 217) in relation to the protease-inhibitory sites of BBI. The results showed that (1) the binding of mAb 238 can be blocked by trypsin and that of mAb 217 by chymotrypsin; (2) the trypsin or chymotrypsin inhibitory activities of BBI are blocked by mAb 238 or mAb 217, respectively; and (3) mAb 238 failed to recognize a tryptic loop mutant BBI variant and mAb 217 was unable to bind a chymotryptic loop mutant BBI variant. These findings demonstrate that the epitopes recognized by mAb 238 and mAb 217 reside, at least in part, in the tryptic and chymotryptic loops of BBI, respectively.
Similar content being viewed by others
Abbreviations
- BBI:
-
Bowman-Birk protease inhibitor
- mAb:
-
monoclonal antibody
- SBTI:
-
soybean trypsin inhibitor
- AAPF:
-
succinyl-ala-ala-pro-phe-paranitroanilide
- AAPR:
-
succinyl-ala-ala-pro-arg-paranitroanilide
- ELISA:
-
enzyme-linked immunosorbent assay
- PBS:
-
phosphate-buffered saline
- SDS-PAGE:
-
sodium dodecylsulfate polyacrylamide gel electrophoresis.
References
W. B. Armstrong A. R. Kennedy X. S. Wan J. Atiba C. E. McLaren F. L. Meyskens SuffixJr. (2000a) Cancer Epidemiol. Biomarkers Prev. 9 43–47 Occurrence Handle1:CAS:528:DC%2BD3cXptVOmtQ%3D%3D
W. B. Armstrong A. R. Kennedy X. S. Wan T. H. Taylor Q. A. Nguyen J. Jensen W. Thompson W. Lagerberg F. L. Meyskens SuffixJr. (2000b) Clin. Cancer. Res. 6 4684–4691 Occurrence Handle1:CAS:528:DC%2BD3MXotlemsA%3D%3D
N. Z. Baturay H. Roque (1991) Teratog. Carcinog. Mutagen. 11 195–202 Occurrence Handle1:CAS:528:DyaK38Xhs12jsbw%3D
Y. Birk (1985) Int. J. Pept. Protein Res. 25 113–131 Occurrence Handle1:CAS:528:DyaL2MXhs1alsb8%3D
D. L. Brandon A. H. Bates M. Friedman (1989) J. Agric. Food Chem. 37 1192–1196 Occurrence Handle10.1021/jf00088a082 Occurrence Handle1:CAS:528:DyaL1MXksFartLw%3D
D. L. Brandon A. H. Bates M. Friedman (1991) Adv. Exp. Med. Biol. 289 321–337 Occurrence Handle1:CAS:528:DyaK38XhtVCmtbo%3D
D. L. Brandon A. H. Bates M. Friedman (2004) J. Food Sci 69 45–49
P. Chen J. Rose R. Love C. H. Wei B. C. Wang (1992) J. Biol. Chem. 267 1990–1994 Occurrence Handle1:CAS:528:DyaK3sXit1yrtro%3D
X. Du K. Beloussow W. C. Shen (2001) Cancer Lett. 164 135–141 Occurrence Handle10.1016/S0304-3835(01)00381-0 Occurrence Handle1:CAS:528:DC%2BD3MXhtFSltL4%3D
K. Frenkel K. Chrzan C. A. Ryan R. Wiesner W. Troll (1987) Carcinogenesis 8 1207–1212 Occurrence Handle1:CAS:528:DyaL1cXltVykurw%3D
H. Frokiaer L. Horlyck V. Barkholt H. Sorensen S. Sorensen (1994) Food Agric. Immunol. 6 63–72
A. R. Kennedy (1998a.) Pharmacol. Ther. 78 167–209 Occurrence Handle10.1016/S0163-7258(98)00010-2 Occurrence Handle1:CAS:528:DyaK1cXjsVejurk%3D
A. R. Kennedy (1998b.) Am. J. Clin. Nutr. 68 1406S–1412S Occurrence Handle1:CAS:528:DyaK1cXnvV2gurs%3D
A. R. Kennedy P. C. Billings X. S. Wan P. M. Newberne (2002) Nutr. Cancer 43 174–186 Occurrence Handle1:CAS:528:DC%2BD3sXhtV2ls7k%3D
A. R. Kennedy X. S. Wan (2002) Prostate 50 125–133 Occurrence Handle10.1002/pros.10041 Occurrence Handle1:CAS:528:DC%2BD38XhsFSht7Y%3D
J. Koepke U. Ermler E. Warkentin G. Wenzl P. Flecker (2000) J. Mol. Biol. 298 477–491 Occurrence Handle10.1006/jmbi.2000.3677 Occurrence Handle1:CAS:528:DC%2BD3cXisFeks7o%3D
S. B. Malkowicz S. P. Liu G. A. Broderick A. J. Wein A. R. Kennedy R. M. Levin (2003) Neurourol. Urodyn. 22 54–57 Occurrence Handle10.1002/nau.10071 Occurrence Handle1:CAS:528:DC%2BD3sXlt1OgsQ%3D%3D
F. L. Meyskens SuffixJr. (2001) IARC Sci. Publ. 154 49–55 Occurrence Handle1:CAS:528:DC%2BD3MXhslKjsL4%3D
M. Perego (1993) NoChapterTitle A. L. Sonenshein J. A. Hoch R. Losick (Eds) Bacillus subtilis and Other Gram-positive Bacteria: Biochemistry, Physiology, and Molecular Genetics American Society for Microbiology Washington 615–624
J. M. Thornton (1981) J. Mol. Biol. 151 261–287 Occurrence Handle10.1016/0022-2836(81)90515-5 Occurrence Handle1:CAS:528:DyaL38XkslyisQ%3D%3D
van Solingen, P. (2000). US Patent No. 6,063,611
E. Hofe Particlevon P. M. Newberne A. R. Kennedy (1991) Carcinogenesis 12 2147–2150
X. S. Wan T. C. Hamilton J. H. Ware J. J. Donahue A. R. Kennedy (1998) Nutr. Cancer 31 8–17 Occurrence Handle1:CAS:528:DyaK1cXlsVeqtrs%3D Occurrence Handle10.1080/01635589809514672
X. S. Wan F. L. Meyskens W. B. Armstrong T. H. Taylor A. R. Kennedy (1999) Cancer Epidemiol. Biomarkers Prev. 8 601–608 Occurrence Handle1:CAS:528:DyaK1MXltVCrt7g%3D
X. S. Wan D. G. Serota J. H. Ware J. A. Crowell A. R. Kennedy (2002) Nutr. Cancer 43 167–173 Occurrence Handle1:CAS:528:DC%2BD3sXhtV2ls7g%3D Occurrence Handle10.1207/S15327914NC432_7
J. H. Ware X. S. Wan P. Newberne A. R. Kennedy (1999) Dig. Dis. Sci. 44 986–990 Occurrence Handle10.1023/A:1026616832119 Occurrence Handle1:CAS:528:DyaK1MXjtFykt78%3D
H. Witschi A. R. Kennedy (1989) Carcinogenesis 10 2275–2277 Occurrence Handle1:CAS:528:DyaK3cXmvFGhug%3D%3D
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mao, Y., Lai, C., Vogtentanz, G. et al. Monoclonal Antibodies Against Soybean Bowman-Birk Inhibitor Recognize the Protease-Reactive Loops. Protein J 24, 275–282 (2005). https://doi.org/10.1007/s10930-005-6748-6
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10930-005-6748-6